Jeroen Roosendaal
Netherlands Forensic Institute(NL)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Epigenetics and DNA Methylation, Forensic Toxicology and Drug Analysis, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research
Most-Cited Works
- → A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer(2017)46 cited
- → 3′-Phosphoadenosine 5′-phosphosulfate synthase 1 (PAPSS1) knockdown sensitizes non-small cell lung cancer cells to DNA damaging agents(2015)22 cited
- → Phase I pharmacological study of continuous chronomodulated capecitabine treatment(2020)18 cited
- → Development and validation of LC-MS/MS methods for the quantification of the novel anticancer agent guadecitabine and its active metabolite β‑decitabine in human plasma, whole blood and urine(2019)12 cited
- → Development, validation, and clinical application of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantification of total intracellular β-decitabine nucleotides and genomic DNA incorporated β-decitabine and 5-methyl-2′-deoxycytidine(2018)10 cited
- → Determination of the absolute bioavailability of oral imatinib using a stable isotopically labeled intravenous imatinib-d8 microdose(2020)9 cited
- → Combining Isotopic Tracer Techniques to Increase Efficiency of Clinical Pharmacokinetic Trials in Oncology(2020)8 cited
- → Mass balance and metabolite profiling of 14C-guadecitabine in patients with advanced cancer(2019)7 cited
- → Population Pharmacokinetics of Intracellular 5-Fluorouridine 5′-Triphosphate and its Relationship with Hand-and-Foot Syndrome in Patients Treated with Capecitabine(2021)5 cited
- → The domain architecture of the protozoan protein J-DNA–binding protein 1 suggests synergy between base J DNA binding and thymidine hydroxylase activity(2019)5 cited